142 related articles for article (PubMed ID: 9203083)
21. Calretinin-immunoreactive dopaminergic neurons from embryonic rat mesencephalon are resistant to levodopa-induced neurotoxicity.
Isaacs KR; Wolpoe ME; Jacobowitz DM
Exp Neurol; 1997 Jul; 146(1):25-32. PubMed ID: 9225735
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats.
Sethy VH; Wu H; Oostveen JA; Hall ED
Brain Res; 1997 Apr; 754(1-2):181-6. PubMed ID: 9134974
[TBL] [Abstract][Full Text] [Related]
23. Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: role of mesencephalic glia.
Engele J; Schubert D; Bohn MC
J Neurosci Res; 1991 Oct; 30(2):359-71. PubMed ID: 1686785
[TBL] [Abstract][Full Text] [Related]
24. Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons.
Salum C; Raisman-Vozari R; Michel PP; Gomes MZ; Mitkovski M; Ferrario JE; Ginestet L; Del Bel EA
Brain Res; 2008 Mar; 1198():27-33. PubMed ID: 18255050
[TBL] [Abstract][Full Text] [Related]
25. FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons.
Castilho RF; Hansson O; Brundin P
Exp Neurol; 2000 Jul; 164(1):94-101. PubMed ID: 10877919
[TBL] [Abstract][Full Text] [Related]
26. Antidepressant effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
J Neural Transm (Vienna); 1997; 104(4-5):525-33. PubMed ID: 9295183
[TBL] [Abstract][Full Text] [Related]
27. Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons.
Engele J
J Neurosci Res; 1998 Aug; 53(4):405-14. PubMed ID: 9710260
[TBL] [Abstract][Full Text] [Related]
28. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
[TBL] [Abstract][Full Text] [Related]
29. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test.
Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G
Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263
[TBL] [Abstract][Full Text] [Related]
30. Toxic and protective effects of L-dopa on mesencephalic cell cultures.
Mytilineou C; Han SK; Cohen G
J Neurochem; 1993 Oct; 61(4):1470-8. PubMed ID: 8376999
[TBL] [Abstract][Full Text] [Related]
31. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
Mena MA; Casarejos MJ; García de Yébenes J
J Neural Transm (Vienna); 1999; 106(11-12):1105-23. PubMed ID: 10651107
[TBL] [Abstract][Full Text] [Related]
32. Pramipexole protects against H2O2-induced PC12 cell death.
Fujita Y; Izawa Y; Ali N; Kanematsu Y; Tsuchiya K; Hamano S; Tamaki T; Yoshizumi M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):257-66. PubMed ID: 16362428
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats.
Lorenc-Koci E; Wolfarth S
Eur J Pharmacol; 1999 Nov; 385(1):39-46. PubMed ID: 10594343
[TBL] [Abstract][Full Text] [Related]
34. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
[TBL] [Abstract][Full Text] [Related]
35. Differential sensitivity of mesencephalic neurons to inhibition of phosphatase 2A.
Zeevalk GD; Bernard LP; Manzino L; Sonsalla PK
J Pharmacol Exp Ther; 2001 Sep; 298(3):925-33. PubMed ID: 11504786
[TBL] [Abstract][Full Text] [Related]
36. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.
Sortwell CE; Camargo MD; Pitzer MR; Gyawali S; Collier TJ
Exp Neurol; 2001 May; 169(1):23-9. PubMed ID: 11312554
[TBL] [Abstract][Full Text] [Related]
37. Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro.
Asanuma M; Miyazaki I; Diaz-Corrales FJ; Shimizu M; Tanaka K; Ogawa N
Neurol Res; 2005 Jul; 27(5):533-9. PubMed ID: 15978181
[TBL] [Abstract][Full Text] [Related]
38. Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons.
Reiriz J; Espejo M; Ventura F; Ambrosio S; Alberch J
J Neurobiol; 1999 Feb; 38(2):161-70. PubMed ID: 10022564
[TBL] [Abstract][Full Text] [Related]
39. Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons.
Li A; Guo H; Luo X; Sheng J; Yang S; Yin Y; Zhou J; Zhou J
FASEB J; 2006 Jun; 20(8):1263-5. PubMed ID: 16636101
[TBL] [Abstract][Full Text] [Related]
40. Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid.
Mena MA; Pardo B; Paino CL; De Yebenes JG
Neuroreport; 1993 Apr; 4(4):438-40. PubMed ID: 8499605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
